Premium
Role of potassium channels in the antinociception induced by agonists of α 2 ‐adrenoceptors
Author(s) -
Galeotti Nicoletta,
Ghelardini Carla,
Vinci Maria Cristina,
Bartolini Alessandro
Publication year - 1999
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702395
Subject(s) - potassium , potassium channel , chemistry , pharmacology , biophysics , neuroscience , medicine , biology , organic chemistry
The effect of the administration of pertussis toxin (PTX) as well as modulators of different subtypes of K + channels on the antinociception induced by clonidine and guanabenz was evaluated in the mouse hot plate test. Pretreatment with pertussis toxin (0.25 μg per mouse i.c.v.) 7 days before the hot‐plate test, prevented the antinociception induced by both clonidine (0.08–0.2 mg kg −1 , s.c.) and guanabenz (0.1–0.5 mg kg −1 , s.c.). The administration of the K ATP channel openers minoxidil (10 μg per mouse, i.c.v.), pinacidil (25 μg per mouse, i.c.v.) and diazoxide (100 mg kg −1 , p.o.) potentiated the antinociception produced by clonidine and guanabenz whereas the K ATP channel blocker gliquidone (6 μg per mouse, i.c.v.) prevented the α 2 adrenoceptor agonist‐induced analgesia. Pretreatment with an antisense oligonucleotide (aODN) to mKv1.1, a voltage‐gated K + channel, at the dose of 2.0 nmol per single i.c.v. injection, prevented the antinociception induced by both clonidine and guanabenz in comparison with degenerate oligonucleotide (dODN)‐treated mice. The administration of the Ca 2+ ‐gated K + channel blocker apamin (0.5–2.0 ng per mouse, i.c.v.) never modified clonidine and guanabenz analgesia. At the highest effective doses, none of the drugs used modified animals' gross behaviour nor impaired motor coordination, as revealed by the rota‐rod test. The present data demonstrate that both K ATP and mKv1.1 K + channels represent an important step in the transduction mechanism underlying central antinociception induced by activation of α 2 adrenoceptors.British Journal of Pharmacology (1999) 126 , 1214–1220; doi: 10.1038/sj.bjp.0702395